Kenneth W. Locke, Chief Scientific Officer at Neothetics, Inc. (NEOT), sold 6,098 shares at $8.30 ($51K) on 2015-11-18, disclosed to the SEC on 2015-11-19.
Scheduled sale ($51k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.